Skip to content

KRRO

Korro Bio, Inc.

NASDAQ · USHealthcareBiotechnology
$12.16-0.73%

Price as of Jul 20, 2026

KRRO earnings

Korro Bio, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 11, 2026in NaN days
EPS est $-1.34 · Revenue est $214286
Track record
Beat EPS in 5 of 11 quarters
Avg surprise -36.0% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-1.60$-1.69-5.6%
Mar 12, 2026$-2.07$-5.32-157.0%$1M+204.0%
Nov 12, 2025$-2.61$-1.92+26.4%$1M+156.5%
Aug 12, 2025$-2.54$-2.74-7.9%$1M+355.1%
May 7, 2025$-2.60$-2.49+4.2%$3M+497.3%
Mar 18, 2025$-2.33$-2.26+3.0%$2M
Aug 13, 2024$-2.40$-2.43-1.3%
Mar 29, 2024$-2.36$-25.65-986.9%
Nov 2, 2023$-17.73$-15.50+12.6%
Aug 10, 2023$-0.44$-0.30+31.8%
May 12, 2023$-0.39$-0.55-41.0%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.